Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes
eClinicalMedicine in conversation with - Een podcast door The Lancet Group

Categorieën:
Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse. Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm Continue this conversation on social! Follow us today at... h...